SLN
Silence Therapeutics·NASDAQ
--
--(--)
--
--(--)
SLN fundamentals
Silence Therapeutics (SLN) released its earnings on Nov 6, 2025: revenue was 159.00K (YoY -89.04%), missed estimates; EPS was -0.15 (YoY +38.20%), beat estimates.
Revenue / YoY
159.00K
-89.04%
EPS / YoY
-0.15
+38.20%
Report date
Nov 6, 2025
EPS
Actual | -0.1054 | -0.1572 | -0.0841 | 0.4524 | -0.1184 | -0.1224 | -0.0922 | -0.1587 | -0.0177 | -0.1427 | -0.2427 | -0.2 | -0.19 | -0.15 | ||
Forecast | -0.1908 | -0.1961 | -0.2011 | -0.0124 | -0.1504 | -0.1729 | -0.1719 | -0.08 | -0.1203 | -0.114 | -0.1275 | -0.1508 | -0.1325 | -0.1871 | ||
Surprise | 0.00% | +44.76% | +19.84% | +58.18% | +3748.39% | +21.28% | +29.21% | +46.36% | -98.38% | +85.29% | -25.18% | -90.35% | 0.00% | -32.63% | -43.40% | +19.83% |
Revenue
Actual | -- | 6.98M | 4.33M | 3.94M | 17.83M | 14.18M | 11.61M | 3.49M | 2.69M | 15.72M | 768.58K | 1.45M | -- | 142.00K | 224.00K | 159.00K |
Forecast | -- | 0 | 0 | 0 | 20.37M | 3.14M | 3.81M | 2.92M | 8.88M | 6.32M | 11.82M | 5.69M | -- | 5.20M | 7.03M | 4.38M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | -12.47% | +351.25% | +204.67% | +19.56% | -69.66% | +148.74% | -93.50% | -74.51% | 0.00% | -97.27% | -96.81% | -96.37% |
Earnings Call
You can ask Aime
What is the revenue and EPS growth rate for Silence Therapeutics year over year?What is Silence Therapeutics's latest dividend and current dividend yield?What is Silence Therapeutics's gross profit margin?What is the market's earnings forecast for Silence Therapeutics next quarter?What does Silence Therapeutics do and what are its main business segments?What were the key takeaways from Silence Therapeutics’s earnings call?Did Silence Therapeutics beat or miss consensus estimates last quarter?What guidance did Silence Therapeutics's management provide for the next earnings period?
